Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 99.99 billion as of March 12, 2026. Its market cap has increased by 6.88% in one year.

Market Cap

99.99B

Enterprise Value

11.61B

Revenue

50.65B

Ranking

n/a

PE Ratio

7.94

Stock Price

14,610.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 99.99B, an increase of 615.85%. That is a compound annual growth rate of 8.92%.

Market Cap History

Date	Market Cap	% Change
Mar 11, 2026	98.48B	9.76%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ViGenCell	117.46B
NovMetaPharma	113.90B
Progen	102.24B
Quratis	99.21B
TegoScience	96.08B
CTCBIO	95.75B
KoBioLabs	87.87B
Choong Ang Vaccine Laboratory	85.51B

Market Cap Rankings